For the third consecutive year, Greenphire has surveyed the clinical trial market worldwide to identify the most critical challenges, priorities, and opportunities to improve the process.
In 2022, a total of 784 industry representatives (274 from sponsors/CROs and 510 from sites) from 51 countries and regions, including the United States, the United Kingdom, Germany, France, Canada, Australia, and Poland participated in the study, which covered the most critical issues while conducting a clinical trial.
Survey respondents represented a variety of therapeutic areas, including cardiovascular, medical device, rare diseases, infectious diseases and oncology.
Download Now